Larimar Therapeutics's total assets for Q3 2024 were $219.02M, a decrease of -7.65% from the previous quarter. LRMR total liabilities were $20.62M for the fiscal quarter, a -19.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.